PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 166 filers reported holding PORTOLA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 3.71 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $190,000 | -90.1% | 10,560 | -96.1% | 0.00% | -92.0% |
Q1 2020 | $1,912,000 | +408.5% | 268,202 | +3759.0% | 0.02% | +257.1% |
Q3 2017 | $376,000 | -56.0% | 6,950 | -54.3% | 0.01% | -61.1% |
Q2 2017 | $854,000 | +165.2% | 15,210 | +7.1% | 0.02% | +200.0% |
Q3 2016 | $322,000 | -90.1% | 14,200 | -89.7% | 0.01% | -91.0% |
Q2 2016 | $3,253,000 | +30.0% | 137,830 | +12.3% | 0.07% | +26.4% |
Q1 2016 | $2,503,000 | – | 122,680 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fernwood Investment Management, LLC | 228,873 | $7,475,000 | 4.17% |
PFM Health Sciences, LP | 5,326,671 | $173,969,000 | 3.54% |
Marcus Capital, LLC | 22,950 | $750,000 | 2.76% |
Partner Investment Management, L.P. | 72,284 | $2,361,000 | 2.55% |
CADIAN CAPITAL MANAGEMENT, LP | 1,240,944 | $40,529,000 | 2.19% |
HARVEY CAPITAL MANAGEMENT INC | 158,580 | $5,179,000 | 1.94% |
SECTORAL ASSET MANAGEMENT INC | 498,412 | $16,278,000 | 1.78% |
Everett Capital Advisors UK LLP | 551,173 | $18,001,000 | 1.52% |
ROSENBLUM SILVERMAN SUTTON S F INC /CA | 125,210 | $4,089,000 | 1.46% |
Atika Capital Management LLC | 113,000 | $3,691,000 | 1.26% |